research

Aethlon Medical, Inc. (AEMD) Q3 2026 Earnings Call Transcript

Seeking Alpha

2 min read

0 likes

⚡ Quantum Brief

Aethlon Medical reported Q3 2026 earnings on February 12, 2026, covering results through December 31, 2025, with CEO/CFO Jim Frakes and CMO Steven LaRosa leading the call. The company emphasized forward-looking statements under SEC regulations, cautioning investors about potential risks tied to projections and ongoing clinical developments. Frakes outlined strategic updates, including advancements in their Hemopurifier® device, targeting viral and cancer therapies, though specific financial or clinical milestones weren’t detailed. Financial highlights were briefly addressed, with full results available on the company’s investor portal, suggesting continued focus on R&D over short-term profitability. Analysts from Zacks, Maxim Group, and H.C. Wainwright participated in Q&A, signaling institutional interest in Aethlon’s pipeline and long-term biotech strategy.

AI Audio Summary

0:00 / 0:00

Click to play

Quantum News · Media Library

Understand this faster with AI

Ask ChatGPT

Research with Perplexity

Explain with Claude

Discuss on Grok

SA Transcripts158.35K FollowersFollow5ShareSaveCommentsPlay Earnings CallPlay Earnings Call Aethlon Medical, Inc. (AEMD) Q3 2026 Earnings Call February 12, 2026 4:30 PM EST Company Participants James Frakes - CEO, CFO, Chief Accounting Officer, Secretary & DirectorSteven Larosa - Chief Medical Officer Conference Call Participants Marla Marin - Zacks Investment Research, Inc.Jeremy Pearlman - Maxim Group LLC, Research DivisionSwayampakula Ramakanth - H.C. Wainwright & Co, LLC, Research Division Presentation Operator Good day, and welcome to the Aethlon Medical Third Quarter Fiscal 2026 Earnings and Corporate Update Conference Call. [Operator Instructions] Please note that this event is being recorded. I would now like to turn the conference over to CEO and CFO, Jim Frakes. Please go ahead. James FrakesCEO, CFO, Chief Accounting Officer, Secretary & Director Thank you, operator, and good afternoon, everyone. Welcome to Aethlon Medical's Fiscal Third Quarter 2026 Earnings Conference Call. My name is Jim Frakes, and I'm the Chief Executive Officer and Chief Financial Officer of Aethlon Medical. At 4:15 p.m. Eastern Time today, Aethlon Medical released financial results for its fiscal third quarter ended December 31, 2025. If you have not seen or received Aethlon Medical's earnings release, please visit the Investors page at www.aethlonmedical.com to view it. Following this introduction and the reading of the company's forward-looking statement disclaimer, Dr. Steven LaRosa, our Chief Medical Officer, and I will provide an overview of Aethlon's strategy and recent developments. I will then make some brief remarks on Aethlon's financials. We will then open up the call for the Q&A session. Before we start the business portion of the call, please note that the news release today and this call contain forward-looking statements within the meaning of the Securities Act of 1933 as amended and the Securities Exchange Act of 1934 as amended. The company cautions you that any statement that is not a statement of

Read Original

Source Information

Source: Seeking Alpha

Website: https://seekingalpha.com/feed.xml

Discussion

0 professional contributions

Be the first to add a constructive contribution.